secwatch.observer — SEC 8-K summary
======================================

Issuer:     Panbela Therapeutics, Inc. (—)
CIK:        0001029125
Form:       8-K
Filed at:   2024-03-07T23:59:59+00:00
Accession:  0001437749-24-006889
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq delists Panbela Therapeutics; trading suspended March 7, 2024
--------------------------------------------------------------------

- Nasdaq notified Panbela of delisting due to failure to meet $2.5M stockholders' equity requirement.
- Trading suspended at open on March 7, 2024; stock expected to quote on OTC Pink Market under PBLA.
- Company has 15 days to request review of Panel's decision by Nasdaq Listing Council.
- Company plans to continue filing periodic reports with SEC despite delisting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1029125/000143774924006889/0001437749-24-006889-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1029125/000143774924006889/pbla20240306_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-006889

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer